Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sabra Health Care REITSBRA -0.20%79 5-Year Yield-on-Cost % is 5.48 as of Jul. 19, 2026, which is 27% below its 10-year median of 7.52. GuruFocus rates SBRA with a GF Score™ of 79/100 and a GF Value™ of $19.53 (Fairly Valued). The stock has 11 warning signs investors should review. Among 876 REITs companies, Sabra Health Care REIT ranks worse than 69.18% on this metric.
Sabra Health Care REIT's yield on cost for the quarter that ended in Mar. 2026 was 5.48.
The historical rank and industry rank for Sabra Health Care REIT's 5-Year Yield-on-Cost % or its related term are showing as below:
SBRA'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 5.31 Med: 7.52 Max: 18.46
Current: 5.48
During the past 13 years, Sabra Health Care REIT's highest Yield on Cost was 18.46. The lowest was 5.31. And the median was 7.52.
SBRA's 5-Year Yield-on-Cost % is ranked worse than 69.18% of 876
companies
in the REITs industry
Industry Median: 7.3
vs SBRA: 5.48
Sabra Health Care REIT (NAS:SBRA) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Sabra Health Care REIT 5-Year Yield-on-Cost % Related Terms
SBRA vs NHI, HR, MPT: 5-Year Yield-on-Cost % Comparison
For the REIT - Healthcare Facilities subindustry, Sabra Health Care REIT's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sabra Health Care REIT 5-Year Yield-on-Cost % vs REITs Industry
For the REITs industry and Real Estate sector, Sabra Health Care REIT's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Sabra Health Care REIT's 5-Year Yield-on-Cost % falls into.
Sabra Health Care REIT 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Sabra Health Care REIT (SBRA) has a 5-Year Yield-on-Cost % of 5.48 as of Jul. 19, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Sabra Health Care REIT and its competitors. This is 27% below median its historical median of 7.52. Over the past decade, Sabra Health Care REIT's 5-Year Yield-on-Cost % has ranged from 5.31 to 18.46. According to the industry distribution chart, Sabra Health Care REIT ranks #606 out of 876 companies in the REITs industry, placing it in the top 69.2%.
Is Sabra Health Care REIT's 5-Year Yield-on-Cost % too high?
Sabra Health Care REIT's current 5-Year Yield-on-Cost % of 5.48 is 27% below median its 10-year median of 7.52. Over the past 10 years, this metric has ranged from a low of 5.31 to a high of 18.46. The REITs industry median 5-Year Yield-on-Cost % is 7.30. Sabra Health Care REIT's value of 5.48 is 24.9% below this industry median. Based on the distribution chart, Sabra Health Care REIT ranks #606 out of 876 companies in the REITs industry, which is below the industry midpoint. Overall, Sabra Health Care REIT has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sabra Health Care REIT's 5-Year Yield-on-Cost % compare to NHI and HR?
According to the REITs industry distribution chart, Sabra Health Care REIT ranks #606 out of 876 companies for 5-Year Yield-on-Cost %. This places Sabra Health Care REIT in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 7.30. Sabra Health Care REIT's value of 5.48 is 24.9% below this benchmark. Historically, Sabra Health Care REIT's own 5-Year Yield-on-Cost % has ranged from 5.31 to 18.46 over the past decade. While the company's 10-year median is 7.52 vs. the industry median of 7.30, Sabra Health Care REIT has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a REITs company?
The median 5-Year Yield-on-Cost % among REITs companies is 7.30, based on 876 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sabra Health Care REIT's current 5-Year Yield-on-Cost % of 5.48 is 24.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Sabra Health Care REIT and its competitors. For the REITs industry, the median 5-Year Yield-on-Cost % is 7.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sabra Health Care REIT's current 5-Year Yield-on-Cost % is 5.48, which is 27% below median its own 10-year median of 7.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sabra Health Care REIT stock overvalued right now?
Based on GuruFocus' analysis, Sabra Health Care REIT (SBRA) is currently considered Fairly Valued. The stock's GF Value™ is $19.53, compared to a current price of $20.11 — trading 2.9% above its estimated fair value. The current 5-Year Yield-on-Cost % is 5.48, which is 27% below median its 10-year median of 7.52 and 24.9% below the REITs industry median of 7.30. Sabra Health Care REIT's overall GF Score™ is 79/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Sabra Health Care REIT (SBRA), the current 5-Year Yield-on-Cost % is 5.48 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sabra Health Care REIT (SBRA) Overvalued in 2026?
Based on GuruFocus' analysis, Sabra Health Care REIT stock appears to be overvalued.
The current stock price of $20.11 is trading 2.9% above its estimated GF Value™ of $19.53.
GuruFocus considers Sabra Health Care REIT to be Fairly Valued.
Key valuation signals for SBRA:
5-Year Yield-on-Cost %: 5.48 (27% below median its 10-year median of 7.52)
GF Value™: $19.53 vs. price of $20.11 (2.9% above fair value)
Industry Position: 24.9% below the REITs median (#606 of 876)
No single metric tells the full story. See the SBRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sabra Health Care REIT Inc is a healthcare facility real estate investment trust. The company operates one segment that owns and invests in healthcare real estate. All of the company's revenue is generated in the United States. Sabra's operations consist of nursing facilities, assisted living centers, and mental health facilities.
79GF Score
Get the complete analysis for SBRA
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SBRA has been successfully added to your 
